<SEC-DOCUMENT>0000950170-25-073555.txt : 20250516
<SEC-HEADER>0000950170-25-073555.hdr.sgml : 20250516
<ACCEPTANCE-DATETIME>20250516161509
ACCESSION NUMBER:		0000950170-25-073555
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250512
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250516
DATE AS OF CHANGE:		20250516

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Syndax Pharmaceuticals Inc
		CENTRAL INDEX KEY:			0001395937
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				320162505
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37708
		FILM NUMBER:		25959426

	BUSINESS ADDRESS:	
		STREET 1:		730 THIRD AVENUE
		STREET 2:		9TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		781-419-1400

	MAIL ADDRESS:	
		STREET 1:		730 THIRD AVENUE
		STREET 2:		9TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sndx-20250512.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-05-16T10:29:25.7323+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sndx="http://www.syndax.com/20250512" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_d1838164-9742-4c00-8f92-76078a34e3fe" name="dei:EntityCentralIndexKey" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff">0001395937</ix:nonNumeric><ix:nonNumeric id="F_b16290c2-060e-4dd6-8a41-4c00a25b24b8" name="dei:AmendmentFlag" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="sndx-20250512.xsd"/></ix:references><ix:resources><xbrli:context id="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001395937</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-12</xbrli:startDate><xbrli:endDate>2025-05-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><h2 style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_93c76d3e-6477-4e11-ba05-a1c26f448387" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></h2><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_c2a07f97-f57a-492e-8137-660863b27396" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">May 12, 2025</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2a96dddf-54a4-4480-b628-72b8c6352890" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SYNDAX PHARMACEUTICALS, INC.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:18%;box-sizing:content-box;"/>
     <td style="width:41%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7fcd7c91-f77e-484d-9697-9ba2a53ce1a1" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_1bbf73e9-fc69-42fa-b13b-fba3a261db55" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-37708</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_71802daf-5d33-47c8-b0f9-96d676c87777" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">32-0162505</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_ca5f1bf5-b2a7-4caf-8a87-2515c0d9cc3e" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">730 THIRD AVENUE</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_32e30c97-e842-417d-9efc-b7fb42157963" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">FLOOR 9</span></ix:nonNumeric></span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_87a8d23f-5dae-4027-8931-d1dd4dbbb96e" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">NEW YORK</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_c25e4f8a-ecd7-40a9-a56d-0108a7a76376" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">New York</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_8f83b23e-3646-4953-adec-a21ede8b53b1" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">10017</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_48922bc2-db04-42ab-bd58-67d03a94c88e" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(781)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_1f0b21e7-cd59-47dd-9631-e97abda2e9f1" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">419-1400</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:3pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_df0cc342-c6ba-430f-bec6-25200f78cb7e" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3ce450b3-30c0-4e73-8e7e-2fa7f23a9991" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_61e60b87-1a0b-49b8-aabf-d1079bde03c2" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3c4a1cfa-7437-4599-8045-9cab6d3a68f1" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:38%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:45%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_ca6bbd95-5798-4ac0-8520-1be4000707d6" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_cd299d99-e0e9-4de1-b0fa-75f8180759b0" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SNDX</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9b151207-b770-4df6-bf80-b02a232bc832" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_405f8448-c9d3-4ab2-872f-9f198861ded1" contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 12, 2025, the Company issued a press release announcing that Nicholas A.J. Botwood, BSC (HONS), MB BS, MFPM, FRCP, will join the Company as Head of Research and Development, Chief Medical Officer, effective May 12, 2025. Prior to joining the Company as Head of Research and Development, Chief Medical Officer, Dr. Botwood served as a consultant. Also on May 12, 2025, Neil Gallagher, M.D. Ph.D, President, Head of Research and Development of the Company, notified the Company of his intention to resign from his position as President, Head of Research and Development. Dr. Gallagher will continue with the Company for an interim period to support the transition.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to joining the Company, Dr. Botwood served as Senior Vice President, Head of Worldwide Medical Oncology at Bristol Myers Squibb and previously served as Bristol Myers Squibb&#8217;s Head of U.S. Medical and Head of Oncology Clinical Development. Prior to joining Bristol Myers Squibb, he served as Head of Oncology Clinical Development and Head of Global Clinical Operations at AstraZeneca. Dr. Botwood holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Imperial College London and a Bachelor of Science (BSc) from University College London. He is a member of the Faculty of Pharmaceutical Medicine and an elected Fellow of the Royal College of Physicians UK.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are no arrangements or understandings with the Company pursuant to which Dr. Botwood was appointed to serve as Head of Research and Development, Chief Medical Officer. There are no family relationships between Dr. Botwood and any director or executive officer of the Company, and there are no related party transactions of the kind described in Item 404(a) of Regulation S-K in which Dr. Botwood was a participant.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with his appointment, the Company entered into an employment agreement with Dr. Botwood, effective May 12, 2025 (the &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employment Agreement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;), providing for the terms of his employment, including an annual base salary of $540,000 and an annual target bonus equal to 45% of his base salary, which bonus will be pro-rated for 2025. Additionally, Dr. Botwood received a stock option award to purchase 215,000 shares of the Company&#8217;s common stock, exercisable at a price per share equal to the closing price of the Company&#8217;s common stock on the Nasdaq Global Select Market on May 1, 2025, the date that the Compensation Committee of the Company&#8217;s Board of Directors approved Dr. Botwood&#8217;s grant following the commencement of a consulting agreement between the Company and Dr. Botwood on April 29, 2025. Twenty-five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the consulting commencement date, and one thirty sixth (1/36th) of the remaining shares of common stock subject to such option shall vest monthly thereafter over the following thirty-six (36) months until all of the shares subject to such option are fully vested, subject to continued service. Dr. Botwood also received a performance restricted stock unit (the &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">PRSU</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;) award of 23,400 units. The number of shares of common stock acquired upon vesting of the PRSU is contingent upon the achievement of pre-established performance metrics, as approved by the Company&#8217;s Compensation Committee of the Board of Directors, subject to Dr. Botwood&#8217;s continued service with the Company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. Botwood&#8217;s employment agreement further provides that in the event his employment is terminated without &#8220;cause,&#8221; as defined in his employment agreement, or he terminates his employment for &#8220;good reason,&#8221; as defined in his employment agreement, he is entitled to (i) a lump sum severance payment equal to nine months base salary, (ii) payment on his behalf of up to nine months of health insurance benefits continuation and (iii) with respect to equity awards granted to Dr. Botwood prior to the date of his termination, accelerated vesting and the lapse of any reacquisition or repurchase rights that the Company holds with respect to such equity awards for the portion of such equity awards that would have otherwise vested within the 12-month period following the date of Dr. Botwood&#8217;s termination were he to remain employed with the Company during such 12-month period. If Dr. Botwood&#8217;s employment is terminated without cause or he terminates his employment for good reason within three months prior to, or 12 months after, a &#8220;change in control&#8221; of the Company, as defined in his employment agreement, he is instead entitled to (a) a lump sum severance payment equal to the sum of 18 months base salary and 100% of the greater of (1) the average annual target performance bonus paid to him for the preceding three years or (2) his annual target performance bonus in effect as of the change in control, (b) payment on his behalf of up to 18 months of health insurance benefits continuation and (c) full accelerated vesting on all of his unvested options and the lapse of any reacquisition or repurchase rights that the Company holds with respect to any other equity award granted to him pursuant to any of the Company&#8217;s equity incentive plans. To receive his severance benefits, Dr. Botwood must sign a general release of claims.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. Botwood&#8217;s employment agreement further provides that in the event the severance and other benefits provided for or otherwise payable to him constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Code and are subject to the excise tax imposed by Section 4999 of the Code, the Company will pay either (i) Dr. Botwood&#8217;s severance benefits under the employment agreement in full or (ii) only a part of Dr. Botwood&#8217;s severance benefits under the employment agreement such that Dr. Botwood receives the largest payment possible without the imposition of the excise tax, in each case, depending upon which alternative would result in Dr. Botwood receiving the greater net after-tax payment.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with his appointment as Head of Research and Development, Chief Medical Officer Dr. Botwood entered into the Company&#8217;s standard form of Indemnification Agreement, a copy of which was filed as Exhibit 10.21 to the Registration Statement on Form S-1 (File No. 333-208861) filed with the SEC on January 4, 2016.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The foregoing description of the Employment Agreement does not purport to be complete and is qualified in its entirety by the full text of the Employment Agreement, a copy of which is furnished as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. A copy of the Company&#8217;s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></p><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5.07  Submission of Matters to a Vote of Security Holders.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company held its annual meeting of stockholders (the &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Annual Meeting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;) on May 14, 2025. The proposals set forth below are described in detail in the Company&#8217;s definitive proxy statement filed with the Securities and Exchange Commission on April 1, 2025. Based on the votes cast in person and by proxy, each proposal passed, including the election of each director. The number of votes cast for and against and the number of abstentions and broker non-votes with respect to each matter voted upon are set forth below:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Proposal 1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:  Election of directors:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:25%;box-sizing:content-box;"/>
     <td style="width:25%;box-sizing:content-box;"/>
     <td style="width:25%;box-sizing:content-box;"/>
     <td style="width:25%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Nominee</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">For</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Withheld</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Broker Non-Votes</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Keith A. Katkin</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,552,483</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,880,619</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,852,212</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dennis G. Podlesak</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,082,144</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,350,958</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,852,212</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Aleksandra Rizo, M.D., Ph.D.</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,139,437</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,293,665</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,852,212</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Proposal 2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:  Advisory vote on executive compensation:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:25%;box-sizing:content-box;"/>
     <td style="width:25%;box-sizing:content-box;"/>
     <td style="width:25%;box-sizing:content-box;"/>
     <td style="width:25%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">For</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Against</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Abstain</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Broker Non-Votes</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,495,031</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,829,672</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">108,399</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,852,212</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Proposal 3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:  Ratification of selection of independent registered public accounting firm:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:25%;box-sizing:content-box;"/>
     <td style="width:25%;box-sizing:content-box;"/>
     <td style="width:25%;box-sizing:content-box;"/>
     <td style="width:25%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">For</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Against</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Abstain</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Broker Non-Votes</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,183,107</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,909</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,298</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7.01 Regulation FD Disclosure.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A copy of the Company&#8217;s press release announcing the foregoing is attached to this Current Report on Form 8-K as Exhibit 99.1. The information in this Item 7.01 and in Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference to such filing.</span></p><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></h2>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:8%;box-sizing:content-box;"/>
     <td style="width:92%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.269%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit<br/>No.</span></p><p style="font-size:8pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.25%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p><p style="margin-left:41.747%;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:41.731%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:5.75pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="sndx-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement, dated May 12, 2025, by and between the Company and Dr. Nicholas Botwood</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="sndx-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press Release, dated May 12, 2025</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:44%;box-sizing:content-box;"/>
     <td style="width:4%;box-sizing:content-box;"/>
     <td style="width:46%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">SYNDAX PHARMACEUTICALS, INC.</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 16, 2025</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Michael A. Metzger</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Michael A. Metzger<br/>Chief Executive Officer</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>sndx-ex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html>
 <head>
  <title>EX-10.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.1</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXECUTIVE EMPLOYMENT AGREEMENT</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXECUTIVE EMPLOYMENT AGREEMENT</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (this &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) is entered into as of the 12</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> day of May, 2025 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Execution Date</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), between </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NICHOLAS A.J. BOTWOOD BSC (HONS), MB BS, MFPM, FRCP </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Executive</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and </font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Syndax Pharmaceuticals, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  Certain capitalized terms used in this Agreement are defined in Article 7.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RECITALS</font></p><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is a biopharmaceutical company.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company desires to employ Executive in the position set forth below, and Executive wishes to be employed by the Company in such position, upon the terms and conditions set forth in this Agreement.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AGREEMENT</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOW, THEREFORE</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in consideration of the mutual promises contained herein, the Company and Executive agree as follows:</font></p><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.533%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">Article 1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PRELIMINARY MATTERS</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">1.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effectiveness of Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  This Agreement shall be effective on the Execution Date.</font></div></div><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.533%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">Article 2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TERMS OF EMPLOYMENT</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Appointment</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Executive&#x2019;s start date with the Company is May 12, 2025 or such other date as mutually agreed upon by the Company and Executive (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Start Date</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  Executive shall serve as Head of Research &amp; Development, Chief Medical Officer, reporting to the Chief Executive Officer.  As Head of Research &amp; Development, Chief Medical Officer, Executive will have such duties and responsibilities typically associated with such officer plus other reasonable duties as may from time to time be assigned to Executive.  During Executive&#x2019;s employment with the Company, Executive shall (i) devote substantially all of Executive&#x2019;s business efforts to the Company, and may (a) participate in charitable, civic, educational, professional, community or industry affairs, and (b) serve as a board member, advisor or a similar position, of up to two other companies, subject to approval by the Company&#x2019;s Nominating and Corporate Governance Committee of the Board of Directors, so long as such service does not conflict with or is not detrimental to the Company&#x2019;s best interests, as determined in good faith by the Board, and (ii) faithfully and to the best of Executive&#x2019;s abilities and experience, and in accordance with the standards and ethics of the business in which the Company is engaged, perform all duties that may be required of Executive by this Agreement, the Company&#x2019;s policies and procedures, and such other duties and responsibilities as may be assigned to Executive from time to time, as well as the directives of the Board.  During Executive&#x2019;s employment with the Company, Executive shall not engage in any activity that conflicts with or is detrimental to the Company&#x2019;s best interests, as determined by the Board.  Executive and the Company acknowledge that Executive&#x2019;s primary office will be remotely located, but that Executive will be required to make frequent visits to the Company&#x2019;s New York, NY headquarters.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employment Term</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Executive will be employed by the Company on an &#x201c;at-will&#x201d; basis.  This means that either the Company or Executive may terminate Executive&#x2019;s employment at any time, for any reason, with or without Cause, and with or without advance notice (provided that Resignation for Good Reason (as defined below) requires certain advanced notice by Executive.  It also means that Executive&#x2019;s job title, duties, responsibilities, reporting level, compensation and benefits, as well as the Company&#x2019;s personnel policies and procedures, may be changed with or without notice at any time in the Company&#x2019;s sole discretion.  This at-will employment relationship shall not be modified by any conflicting actions or representations of any Company employee or other party before or during the term of Executive&#x2019;s employment.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annual Base Salary</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Executive&#x2019;s annual base salary shall be $540,000 per year (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Annual Base Salary</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), payable in equal installments, less applicable deductions and withholdings, in accordance with the Company&#x2019;s standard payroll practices.  Executive&#x2019;s Annual Base Salary shall be subject to review by the Company&#x2019;s compensation committee and may be increased or decreased from time to time, but shall not be reduced unless, and only to the extent that, the base salaries of all other similarly situated executives of the Company are proportionately reduced.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Benefits</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Executive will be entitled to participate in all of the employee benefits and benefit plans that the Company generally makes available to its full-time employees and executives and for which Executive is eligible in accordance with the Company&#x2019;s policies as in effect from time to time.  These benefits are subject to the terms, conditions, and eligibility requirements that govern or apply to them.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bonus</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In addition to Annual Base Salary, Executive shall be eligible to earn an annual performance bonus of up to forty-five percent (45%) of Executive&#x2019;s Annual Base Salary, which bonus shall be earned upon Executive&#x2019;s attainment of objectives to be determined by the Board (or the compensation committee thereof, as such determination may be delegated by the Board to the compensation committee) and continued employment with the Company as described below (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Target Performance Bonus</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  The amount of and Executive&#x2019;s eligibility for the Target Performance Bonus shall be determined in the sole discretion of the Board (or the compensation committee thereof, as such determination may be delegated by the Board to the compensation committee).  If earned, any Target Performance Bonus shall be paid to Executive, less authorized deductions and applicable withholdings, on or before the February 15th following the applicable bonus year.  For the 2025 calendar year, if earned, the Target Performance Bonus will be pro-rated from the Start Date.  Except as provided in Sections 3.2 and 4.2, Executive shall be eligible to earn the Target Performance Bonus only if Executive is actively employed and in good standing with the Company on both the determination and payment dates for the Target Performance Bonus.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reimbursement of Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Subject to Section 5.10(c), the Company shall reimburse Executive for Executive&#x2019;s necessary and reasonable business expenses incurred in connection with Executive&#x2019;s duties in accordance with the Company&#x2019;s generally applicable policies.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.5</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Executive&#x2019;s outstanding equity awards received upon commencement of his consulting agreement with the Company will continue to vest in accordance with the terms of such awards.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.533%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">Article 3</font><div style="width:100%;display:inline;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CHANGE IN CONTROL SEVERANCE BENEFITS</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3.1</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Severance Benefits</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Upon a Change in Control Termination, and subject to the limitations and conditions set forth in this Agreement, Executive shall be eligible to receive the benefits set forth in this Article 3.  The receipt of any severance payments or benefits pursuant to this Agreement is subject to Executive signing and not revoking a separation agreement and general release of claims (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Release</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), in substantially the form attached hereto and incorporated herein as </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit C</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as appropriate, which Release must become effective and irrevocable no later than the sixtieth (60</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) day following Executive&#x2019;s termination of employment (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Release Deadline Date</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  If the Release does not become effective and irrevocable by the Release Deadline Date, Executive will forfeit any right to any severance payments or benefits under this Agreement.  In no event will severance payments or benefits be paid or provided until the Release actually becomes effective and irrevocable</font></p><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">3.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Salary and Pro-Rata Bonus Payment</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In consideration of Executive&#x2019;s execution and non-revocation of the Release by the Release Deadline Date in a form provided by the Company and in accordance with Article 4, the Company shall pay Executive a severance payment equal to (a) the sum of Executive&#x2019;s Monthly Base Salary and Pro-Rata Bonus multiplied by (b) the number of months in the Change in Control Severance Period, less applicable withholdings.  The severance payment shall be payable (except as set forth in Article 5) in a lump sum on the first regularly-scheduled payroll date occurring on or after the Release Deadline Date. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">3.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Health Continuation Coverage.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provided that Executive is eligible and has made the necessary elections for continuation coverage pursuant to COBRA under a health, dental or vision plan sponsored by the Company, the Company shall pay the applicable premiums (inclusive of premiums for Executive&#x2019;s dependents for such health, dental or vision plan coverage as in effect immediately prior to the date of the Change in Control Termination) for such continued health, dental or vision plan coverage following the date of the Change in Control Termination for up to the number of months equal to the Change in Control Benefits Period (but in no event after such time as Executive is eligible for coverage under a health, dental or vision insurance plan of a subsequent employer or as Executive and Executive&#x2019;s dependents are no longer eligible for COBRA coverage); provided that if continued payment by the Company of the applicable premiums would result in a violation of the nondiscrimination rules of Section 105(h)(2) of the Internal Revenue Code of 1986, as amended, or any statute or regulation of similar effect (including, without limitation, the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of providing such continued payment, the Company will instead pay Executive on the first day of each month a fully taxable cash payment equal to the applicable premiums for that month, subject to applicable tax withholdings, for the remainder of the Change in Control Benefits Period.  Such coverage shall be counted as coverage pursuant to COBRA.  The Company shall have no obligation in respect of any premium payments (or any other payments in respect of health, dental or vision coverage from the Company) following the effective date of Executive&#x2019;s coverage by a health, dental or vision insurance plan of a subsequent employer.  Executive shall be required to notify the Company immediately if Executive becomes covered by a health, dental or vision insurance plan of a subsequent employer.  If Executive and Executive&#x2019;s dependents continue coverage pursuant to COBRA following the conclusion of the Change in Control Benefits Period, Executive will be responsible for the entire payment of such premiums required under COBRA for the duration of the COBRA period.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of this Section 3.3, (i) references to COBRA shall be deemed to refer also to analogous provisions of state law, and (ii) any applicable insurance premiums that are paid by the </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company shall not include any amounts payable by Executive under a Code Section 125 health care reimbursement plan, which amounts, if any, are the sole responsibility of Executive.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">3.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Upon a Change in Control Termination, (a) the vesting and exercisability of all outstanding options to purchase the Company&#x2019;s common stock (or stock appreciation rights or other rights with respect to the stock of the Company issued pursuant to any equity incentive plan of the Company) that are held by Executive on the Termination Date shall be accelerated in full, (b) any reacquisition or repurchase rights held by the Company with respect to common stock issued or issuable (or with respect to other rights with respect to the stock of the Company issued or issuable) pursuant to any other stock award granted to Executive pursuant to any equity incentive plan of the Company shall lapse and (c) the time period that Executive has to exercise any outstanding options to purchase the Company&#x2019;s common stock that are held by Executive on the Termination Date shall be extended for a period equal to the shorter of (i) twelve (12) months or (ii) the remaining term of the outstanding option.</font></div></div><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.533%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">Article 4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COVERED TERMINATION SEVERANCE BENEFITS</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Severance Benefits</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Upon a Covered Termination, and subject to the limitations and conditions set forth in this Agreement, Executive shall be eligible to receive the benefits set forth in this Article 4.  The receipt of any severance payments or benefits pursuant to this Agreement is subject to Executive signing and not revoking the appropriate Release, which Release must become effective and irrevocable no later than the Release Deadline Date.  If the Release does not become effective and irrevocable by the Release Deadline Date, Executive will forfeit any right to any severance payments or benefits under this Agreement.  In no event will severance payments or benefits be paid or provided until the Release actually becomes effective and irrevocable. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Salary Payment</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In consideration of Executive&#x2019;s timely execution and non-revocation of the Release by the Release Deadline Date, the Company shall pay Executive a severance payment equal to Executive&#x2019;s Monthly Base Salary multiplied by the number of months in the Covered Termination Severance Period, less applicable withholdings.  The severance payment shall be payable (except as set forth in Article 5) in a lump sum on the first regularly-scheduled payroll date occurring on or after the Release Deadline Date.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Health Continuation Coverage</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provided that Executive is eligible and has made the necessary elections for continuation coverage pursuant to COBRA under a health, dental or vision plan sponsored by the Company, the Company shall pay for the applicable premiums (inclusive of premiums for Executive&#x2019;s dependents for such health, dental or vision plan coverage as in effect immediately prior to the date of the Covered Termination) for such continued health, dental or vision plan coverage following the date of the Covered Termination for up to the number of months equal to the Covered Termination Benefits Period (but in no event after such time as Executive is eligible for coverage under a health, dental or vision insurance plan of a subsequent employer or as Executive and Executive&#x2019;s dependents are no longer eligible for COBRA coverage); provided that if continued payment by the Company of the applicable premiums would result in a violation of the nondiscrimination rules of Section 105(h)(2) of the Internal Revenue Code of 1986, as amended, or any statute or regulation of similar effect (including, without limitation, the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of providing such continued payment, the Company will instead pay Executive on the first day of each month a fully taxable cash payment equal to the applicable premiums for that month, subject to applicable tax withholdings, for the remainder of the Covered Termination Benefits Period.  Such </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">coverage shall be counted as coverage pursuant to COBRA.  The Company shall have no obligation in respect of any premium payments (or any other payments in respect of health, dental or vision coverage from the Company) following the effective date of Executive&#x2019;s coverage by a health, dental or vision insurance plan of a subsequent employer.  Executive shall be required to notify the Company immediately if Executive becomes covered by a health, dental or vision insurance plan of a subsequent employer.  If Executive and Executive&#x2019;s dependents continue coverage pursuant to COBRA following the conclusion of the Covered Termination Benefits Period, Executive will be responsible for the entire payment of such premiums required under COBRA for the duration of the COBRA period.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of this Section 4.3, (i) references to COBRA shall be deemed to refer also to analogous provisions of state law, and (ii) any applicable insurance premiums that are paid by the Company shall not include any amounts payable by Executive under a Code Section 125 health care reimbursement plan, which amounts, if any, are the sole responsibility of Executive.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Upon a Covered Termination:</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the vesting and exercisability of all outstanding options to purchase the Company&#x2019;s common stock (or stock appreciation rights or other rights with respect to the stock of the Company issued pursuant to any equity incentive plan of the Company) that are held by Executive on the Termination Date shall be accelerated as to the number of shares of common stock issuable upon exercise of such option (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Option Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) as equals the number of Option Shares as would otherwise vest during the twelve (12) month period following the Termination Date in accordance with the applicable options&#x2019; vesting schedule were the Executive to remain an employee of the Company during such twelve (12) month period (disregarding any other basis for acceleration of vesting of Option Shares during such twelve (12) month period);</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any reacquisition or repurchase rights held by the Company with respect to common stock issued or issuable (or with respect to other rights with respect to the stock of the Company issued or issuable) pursuant to any option to purchase the Company&#x2019;s common stock (or stock appreciation rights or other rights with respect to the stock of the Company) (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) held by the Executive as of the Termination Date shall lapse as to the number of Restricted Shares as equals the number of Restricted Shares as to which such reacquisition or repurchase rights would otherwise lapse during the twelve (12) month period following the Termination Date in accordance with the option&#x2019;s vesting schedule were the Executive to remain an employee of the Company during such twelve (12) month period (disregarding any other basis for acceleration of the lapsing of such reacquisition or repurchase rights on Restricted Shares during such twelve (12) month period); and</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the time period that Executive has to exercise any outstanding options to purchase the Company&#x2019;s common stock that are held by Executive on the Termination Date shall be extended for a period equal to the shorter of (i) twelve (12) months or (ii) the remaining term of the outstanding option.</font></div></div><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.533%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">Article 5</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LIMITATIONS AND CONDITIONS ON BENEFITS</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rights Conditioned on Compliance</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Executive&#x2019;s rights to receive all severance benefits described in Article 3 and Article 4 shall be conditioned upon and subject to Executive&#x2019;s compliance with the limitations and conditions on benefits as described in this Article 5.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Continuation of Service Until Date of Termination</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Executive shall continue to provide service to the Company in good faith until the Termination Date, unless such performance is otherwise excused in writing by the Company.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Release Prior to Payment of Benefits</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Upon the occurrence of a Change in Control Termination or a Covered Termination, as applicable, and prior to Executive earning any entitlement to any severance or separation benefits under this Agreement on account of such Change in Control Termination or Covered Termination, as applicable, Executive must execute the appropriate Release, and such Release must become effective in accordance with its terms, but in no event later than the Release Deadline Date.  No amount shall be paid prior to such date.  Instead, on the first regularly-scheduled payroll date occurring on or after the Release Deadline Date, the Company will pay Executive the severance amount that Executive would otherwise have received on or prior to such date but for the delay in payment related to the effectiveness of the Release, with the balance of the severance amount being paid as originally scheduled.  The Company may modify the Release in its discretion to comply with changes in applicable law at any time prior to Executive&#x2019;s execution of such Release.  Such Release shall specifically relate to all of Executive&#x2019;s rights and claims in existence at the time of such execution and shall confirm Executive&#x2019;s obligations under the Confidentiality Agreement and any similar obligations under applicable law.  It is understood that, as specified in the applicable Release, Executive has a certain number of calendar days to consider whether to execute such Release.  If Executive does not execute and deliver such Release within the applicable period, no benefits shall be provided or payable under this Agreement, and Executive shall have no further rights, title or interests in or to any severance benefits or payments pursuant to this Agreement.  It is further understood that if Executive is age 40 or older at the time of a Change in Control Termination or a Covered Termination, as applicable, Executive may revoke the applicable Release within seven (7) calendar days after its execution by Executive.  If Executive revokes such Release within such subsequent seven (7) day period, no benefits shall be provided or payable under this Agreement pursuant to such Change in Control Termination or Covered Termination, as applicable.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Return of Company Property</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Not later than the Termination Date, Executive shall return to the Company all documents (and all copies thereof) and other property belonging to the Company that Executive has in his or her possession or control.  The documents and property to be returned include, but are not limited to, all files, correspondence, email, memoranda, notes, notebooks, records, plans, forecasts, reports, studies, analyses, compilations of data, proposals, agreements, financial information, research and development information, marketing information, operational and personnel information, databases, computer-recorded information, tangible property and equipment (including, but not limited to, computers, facsimile machines, mobile telephones and servers), credit cards, entry cards, identification badges and keys, and any materials of any kind which contain or embody any proprietary or confidential information of the Company (and all reproductions thereof in whole or in part).  Executive agrees to make a diligent search to locate any such documents, property and information.  If Executive has used any personally owned computer, server or e-mail system to receive, store, review, prepare or transmit any Company confidential or proprietary data, materials or information, then within ten (10) business days after the Termination Date, Executive shall provide the Company with a computer-useable copy of all such information and then permanently delete and expunge such confidential or proprietary information from those systems.  Executive agrees to provide the Company access to Executive&#x2019;s system as requested to verify that the necessary copying and/or deletion is done.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.5</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cooperation and Continued Compliance with Restrictive Covenants</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From and after the Termination Date, Executive shall cooperate fully with the Company in connection with its actual or contemplated defense, prosecution or investigation of any existing or future litigation, arbitrations, mediations, claims, demands, audits, government or regulatory inquiries, or other matters arising from events, acts or failures to act that occurred during the time period in which </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive was employed by the Company (including any period of employment with an entity acquired by the Company).  Such cooperation includes, without limitation, being available upon reasonable notice, without subpoena, to provide accurate and complete advice, assistance and information to the Company, including offering and explaining evidence, providing truthful and accurate sworn statements, and participating in discovery and trial preparation and testimony.  Executive also agrees to promptly send the Company copies of all correspondence (for example, but not limited to, subpoenas) received by Executive in connection with any such legal proceedings, unless Executive is expressly prohibited by law from so doing.  The Company will reimburse Executive for reasonable out-of-pocket expenses incurred in connection with any such cooperation (excluding foregone wages, salary or other compensation) within thirty (30) days of Executive&#x2019;s timely presentation of appropriate documentation thereof, in accordance with the Company&#x2019;s standard reimbursement policies and procedures, and will make reasonable efforts to accommodate Executive&#x2019;s scheduling needs.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From and after the Termination Date, Executive shall continue to abide by all of the terms and provisions of the Confidentiality Agreement (and any other comparable agreement signed by Executive), in accordance with its terms. </font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive acknowledges and agrees that Executive&#x2019;s obligations under this Section 5.5 are an essential part of the consideration Executive is providing hereunder in exchange for which and in reliance upon which the Company has agreed to provide the payments and benefits under this Agreement.  Executive further acknowledges and agrees that Executive&#x2019;s violation of this Section 5.5 inevitably would involve use or disclosure of the Company&#x2019;s proprietary and confidential information.  Accordingly, Executive agrees that Executive will forfeit, effective as of the date of any breach, any right, entitlement, claim or interest in or to any unpaid portion of the severance payments or benefits provided in Article 3 or Article 4.  If it is determined by a court of competent jurisdiction in any state that any restriction in this Section 5.5 is excessive in duration or scope or is unreasonable or unenforceable under the laws of that state, it is the intention of the parties that such restriction may be modified or amended by the court to render it enforceable to the maximum extent permitted by the law of that state.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.6</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Parachute Payments</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Parachute Payment Limitation</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If any payment or benefit (including payments and benefits pursuant to this Agreement) Executive would receive in connection with a Change in Control from the Company or otherwise (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Payment</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) would (i) constitute a &#x201c;parachute payment&#x201d; within the meaning of Section 280G of the Code, and (ii) but for this paragraph, be subject to the excise tax imposed by Section 4999 of the Code (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Excise Tax</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), then the Company shall cause to be determined, before any amounts of the Payment are paid to Executive, which of the following two alternative forms of payment shall be paid to Executive: (A) payment in full of the entire amount of the Payment (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Full Payment</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), or (B) payment of only a part of the Payment so that Executive receives the largest payment possible without the imposition of the Excise Tax (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reduced Payment</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  A Full Payment shall be made in the event that the amount received by Executive on a net after-tax basis is greater than what would be received by Executive on a net after-tax basis if the Reduced Payment were made, otherwise a Reduced Payment shall be made.  If a Reduced Payment is made, (i) the Payment shall be paid only to the extent permitted under the Reduced Payment alternative, and Executive shall have no rights to any additional payments and/or benefits constituting the Payment, and (ii) reduction in payments and/or benefits shall occur in the following order: (A) reduction of cash payments; (B) cancellation of accelerated vesting of equity awards other than stock options; (C) cancellation of accelerated vesting of stock options; and (D) reduction of other benefits paid to Executive.  In the event that acceleration of compensation from Executive&#x2019;s equity awards is to be reduced, such acceleration of vesting shall be canceled in the reverse order of the date of grant.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The independent registered public accounting firm engaged by the Company for general audit purposes as of the day prior to the effective date of the Change in Control shall make all determinations required to be made under this Section 5.6.  If the independent registered public accounting firm so engaged by the Company is serving as accountant or auditor for the individual, entity or group effecting the Change in Control, the Company shall appoint a nationally recognized independent registered public accounting firm to make the determinations required hereunder.  The Company shall bear all expenses with respect to the determinations by such independent registered public accounting firm required to be made hereunder.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The independent registered public accounting firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting documentation, to the Company and Executive within fifteen (15) calendar days after the date on which Executive&#x2019;s right to a Payment is triggered (if requested at that time by the Company or Executive) or such other time as requested by the Company or Executive.  If the independent registered public accounting firm determines that no Excise Tax is payable with respect to a Payment, either before or after the application of the Reduced Amount, it shall furnish the Company and Executive with an opinion reasonably acceptable to Executive that no Excise Tax will be imposed with respect to such Payment.  Any good faith determinations of the accounting firm made hereunder shall be final, binding and conclusive upon the Company and Executive. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.7</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain Reductions and Offsets</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  To the extent that any federal, state or local laws, including, without limitation, the Worker Adjustment and Retraining Notification Act or any other so-called &#x201c;plant closing&#x201d; laws, require the Company to give advance notice or make a payment of any kind to Executive because of Executive&#x2019;s involuntary termination due to a layoff, reduction in force, plant or facility closing, sale of business, change in control or any other similar event or reason, the benefits payable under this Agreement shall be correspondingly reduced.  The benefits provided under this Agreement are intended to satisfy any and all statutory obligations that may arise out of Executive&#x2019;s involuntary termination of employment for the foregoing reasons, and the parties shall construe and enforce the terms of this Agreement accordingly.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.8</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mitigation</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Except as otherwise specifically provided herein, Executive shall not be required to mitigate damages or the amount of any payment provided under this Agreement by seeking other employment or otherwise, nor shall the amount of any payment provided for under this Agreement be reduced by any compensation earned by Executive as a result of employment by another employer or by any retirement benefits received by Executive after the date of a Change in Control Termination or Covered Termination (except as expressly provided in Sections 3.3 and 4.3 above). </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.9</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indebtedness of Executive</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If Executive is indebted to the Company on the effective date of a Change in Control Termination or Covered Termination, the Company reserves the right to offset any severance payments and benefits under this Agreement by the amount of such indebtedness. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.10</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Application of Section 409A</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Separation from Service</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Notwithstanding any provision to the contrary in this Agreement, no amount deemed deferred compensation subject to Section 409A of the Code shall be payable pursuant to Article 3 or Article 4 unless Executive&#x2019;s termination of employment constitutes a &#x201c;separation from service&#x201d; with the Company within the meaning of Section 409A of the Code and the Department of Treasury Regulations and other guidance promulgated thereunder and, except as provided under Section 5.10(b) hereof, any such amount shall not be paid, or in the case of installments, commence payment, until the first regularly-scheduled payroll date occurring on or after the sixtieth (60</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) day following Executive&#x2019;s separation from service.  Any installment payments that would have been made to Executive during the sixty (60) day period immediately following Executive&#x2019;s separation from service but for the preceding </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">sentence shall be paid to Executive on the first regularly-scheduled payroll date occurring on or after the sixtieth (60</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) day after Executive&#x2019;s separation from service and the remaining payments shall be made as provided in this Agreement.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specified Executive</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed at the time of his or her separation from service to be a &#x201c;specified employee&#x201d; for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of Executive&#x2019;s benefits shall not be provided to Executive prior to the earlier of (i) the expiration of the six (6)-month period measured from the date of Executive&#x2019;s &#x201c;separation from service&#x201d; with the Company (as such term is defined in the Treasury Regulations issued under Section 409A of the Code) or (ii) the date of Executive&#x2019;s death.  Upon the first business day following the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this Section 5.10(b) shall be paid in a lump sum to Executive, and any remaining payments due under this Agreement shall be paid as otherwise provided herein.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Expense Reimbursements</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  To the extent that any reimbursement payable pursuant to this Agreement is subject to the provisions of Section 409A of the Code, any such reimbursement payable to Executive pursuant to this Agreement shall be paid to Executive no later than December 31 of the year following the year in which the expense was incurred; the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year; and Executive&#x2019;s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Installments</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  For purposes of Section 409A of the Code (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive&#x2019;s right to receive any installment payments under this Agreement shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.11</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tax Withholding</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  All payments under this Agreement shall be subject to applicable withholding for federal, state and local income and employment taxes. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.12</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Duplication of Severance Benefits.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  The severance and other benefits provided in Article 3 and Article 4 are mutually exclusive of each other, and in no event shall Executive receive any severance or other benefits pursuant to both Article 3 and Article 4.</font></div></div><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.533%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">Article 6</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TERMINATION WITH CAUSE OR BY VOLUNTARY RESIGNATION; </font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OTHER RIGHTS AND BENEFITS</font></p><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">6.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Termination for Cause by the Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If the Company shall terminate the Executive&#x2019;s employment with the Company for Cause, then upon such termination, the Company shall have no further obligation to Executive hereunder except for the payment or provision, as applicable, of (a) the portion of the Annual Base Salary for the period prior to the effective date of termination earned but unpaid (if any), (b) all unreimbursed expenses (if any), subject to Sections 2.4 and 5.10(c), and (c) other payments, entitlements or benefits, if any, in accordance with terms of the applicable plans, programs, arrangements or other agreements of the Company (other than any severance plan or policy) as to which the Executive held rights to such payments, entitlements or benefits, whether as a participant, beneficiary or otherwise on the date of termination (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Benefits</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  For the avoidance of doubt, Executive shall have no right to </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">receive (and Other Benefits shall not include) any amounts under any Company severance plan or policy or pursuant to Article 3 or Article 4 upon Executive&#x2019;s termination for Cause.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">6.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Termination by Voluntary Resignation by the Executive (other than Resignation for Good Reason)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Upon any voluntary resignation by Executive that is not a Resignation for Good Reason, the Company shall have no further obligation to the Executive hereunder except for the payment of (a) the portion of the Annual Base Salary for the period prior to the effective date of termination earned but unpaid (if any), (b) all unreimbursed expenses (if any), subject to Sections 2.4 and 5.10(c), and (c) the payment or provision of any Other Benefits.  For the avoidance of doubt, Executive shall have no right to receive (and Other Benefits shall not include) any amounts under any Company severance plan or policy or pursuant to Article 3 or Article 4 upon any voluntary resignation by Executive that is not a Resignation for Good Reason.  </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">6.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other Rights and Benefits.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  Nothing</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in this Agreement shall prevent or limit Executive&#x2019;s continuing or future participation in any benefit, bonus, incentive or other plans, programs, policies or practices provided by the Company and for which Executive may otherwise qualify, nor shall anything herein limit or otherwise affect such rights as Executive may have under other agreements with the Company except as provided in Article 2, Article 5, Section 6.1 and Section 6.2 above.  Except as otherwise expressly provided herein, amounts that are vested benefits or that Executive is otherwise entitled to receive under any plan, policy, practice or program of the Company at or subsequent to the date of a Change in Control shall be payable in accordance with such plan, policy, practice or program. </font></div></div><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.533%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">Article 7</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DEFINITIONS</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise provided, for purposes of this Agreement, the following definitions shall apply:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Board</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Board of Directors of the Company.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cause</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, upon a reasonable determination by the Company, Executive&#x2019;s: (a) dishonest statements or acts with respect to the Company, any subsidiary or any affiliate of the Company or any subsidiary; (b) commission by or indictment for (i) a felony or (ii) any misdemeanor (excluding minor traffic violations) involving moral turpitude, deceit, dishonesty or fraud (&#x201c;indictment,&#x201d; for these purposes, meaning an indictment, probable cause hearing or any other procedure pursuant to which an initial determination of probable or reasonable cause with respect to such offense is made); (c) gross negligence, willful misconduct or insubordination with respect to the Company, any subsidiary or any affiliate of the Company or any subsidiary; (d) material breach of any of Executive&#x2019;s obligations under any agreement to which Executive and the Company or any subsidiary are a party; or (e) death or disability.  With respect to clause (d), Executive will be given notice and a 30-day period in which to cure such breach, only to the extent such breach can be reasonably expected to be able to be cured within such period.  Executive agrees that the breach of any confidentiality obligation to the Company or any subsidiary shall not be curable to any extent.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in Control</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events:</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any natural person, entity or group within the meaning of Section 13(d) or 14(d) of the Securities Exchange Act of 1934, as amended (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exchange Act Person</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), becomes the owner, directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the combined voting power of the Company&#x2019;s then outstanding securities other than by virtue of a merger, consolidation </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or similar transaction.  Notwithstanding the foregoing, a Change in Control shall not be deemed to occur (i) on account of the acquisition of securities of the Company by any institutional investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#x2019;s securities in a transaction or series of related transactions that are primarily a private financing transaction for the Company or (ii) solely because the level of ownership held by any Exchange Act Person (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subject Person</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities owned by the Subject Person over the designated percentage threshold, then a Change in Control shall be deemed to occur;</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is consummated a merger, consolidation or similar transaction involving, directly or indirectly, the Company if, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not own, directly or indirectly, either (i) outstanding voting securities representing more than fifty percent (50%) of the combined outstanding voting power of the surviving entity in such merger, consolidation or similar transaction or (ii) more than fifty percent (50%) of the combined outstanding voting power of the parent of the surviving entity in such merger, consolidation or similar transaction;</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The stockholders of the Company approve or the Board approves a plan of complete dissolution or liquidation of the Company, or a complete dissolution or liquidation of the Company shall otherwise occur; or</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is consummated a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its subsidiaries to an entity, more than fifty percent (50%) of the combined voting power of the voting securities of which are owned by stockholders of the Company in substantially the same proportion as their ownership of the Company immediately prior to such sale, lease, license or other disposition. </font></div></div><p style="text-indent:7.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company.  Notwithstanding the foregoing or any other provision of this Agreement, the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any affiliate and the participant shall supersede the foregoing definition with respect to stock awards subject to such agreement (it being understood, however, that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition shall apply).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in Control Benefits Period</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the period of eighteen (18) months commencing on the Termination Date.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.5</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in Control Severance Period</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the period of eighteen (18) months commencing on the Termination Date.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.6</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in Control Termination</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Involuntary Termination Without Cause</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Resignation for Good Reason</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">,</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; either of which occurs on, or within three (3) months prior to, or within twelve (12) months following, the effective date of a Change in Control, provided that any such termination is a &#x201c;separation from service&#x201d; within the meaning of Treasury Regulation Section 1.409A-1(h). Death and disability shall not be deemed Change in Control Terminations.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.7</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">COBRA</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.8</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Code</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Internal Revenue Code of 1986, as amended.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.9</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means Syndax Pharmaceuticals, Inc.</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or, following a Change in Control, the surviving entity resulting from such transaction, or any subsequent surviving entity resulting from any subsequent Change in Control.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.10</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Confidentiality Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means Executive&#x2019;s Assignment of Developments, Non-Disclosure, and Non-Solicitation Agreement with the Company (or any successor agreement thereto).</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.11</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Covered Termination</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Involuntary Termination Without Cause</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Resignation for Good Reason</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">,</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; provided that any such termination is a &#x201c;separation from service&#x201d; within the meaning of Treasury Regulation Section 1.409A-1(h).  Death and disability shall not be deemed Covered Terminations.  If an Involuntary Termination Without Cause or Resignation for Good Reason qualifies as a Change in Control Termination, it shall not constitute a Covered Termination.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.12</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Covered Termination Benefits Period</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the period of nine (9) months commencing on the Termination Date.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.13</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Covered Termination Severance Period</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the period of nine (9) months commencing on the Termination Date.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.14</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Involuntary Termination Without Cause</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means Executive&#x2019;s dismissal or discharge by the Company for reasons other than Cause and other than as a result of death or disability.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.15</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Monthly Base Salary</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means 1/12</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the greater of (i) Executive&#x2019;s annual base salary (excluding incentive pay, premium pay, commissions, overtime, bonuses and other forms of variable compensation) as in effect on the date of a Change in Control Termination or a Covered Termination, as applicable, or (ii) in the case of a Change in Control Termination, Executive&#x2019;s annual base salary (excluding incentive pay, premium pay, commissions, overtime, bonuses and other forms of variable compensation) as in effect on the date of a Change in Control.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.16</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pro-Rata Bonus</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means 1/12</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the greater of (i) the average Target Performance Bonus paid to Executive for the three years preceding the date of a Change in Control Termination (or such lesser number of years during which Executive has been employed by the Company), or (ii) the Target Performance Bonus, as in effect on the date of a Change in Control Termination.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.17</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Resignation for Good Reason</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means Executive&#x2019;s resignation from all employee positions Executive then holds with the Company within sixty (60) days following any of the following events taken without Executive&#x2019;s consent, provided Executive has given the Company written notice of such event within thirty (30) days after the first occurrence of such event and the Company has not cured such event within thirty (30) days thereafter:</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A decrease in Executive&#x2019;s total target cash compensation (base and bonus) of more than 10% (i.e., a material reduction in Executive&#x2019;s base compensation and a material breach by the Company of Executive&#x2019;s employment terms with the Company), other than in connection with a comparable decrease in compensation for all comparable executives of the Company;</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive&#x2019;s duties or responsibilities are materially diminished (not simply a change in title or reporting relationships); provided, that Executive shall not be deemed to have a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Resignation for Good Reason</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; if the Company survives as a separate legal entity or business unit following the Change in Control and Executive holds materially the same position in such legal entity or business unit as Executive held before the Change in Control;</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Either (i) Executive is required to establish residence in a location more than fifty (50) miles from Executive&#x2019;s current principal personal residence or (ii) there is an increase in Executive&#x2019;s round-trip driving distance of more than fifty (50) miles from Executive&#x2019;s current principal personal residence to the principal office or business location at which Executive is required to perform services (except for required business travel to the extent consistent with Executive&#x2019;s prior business travel obligations) (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Executive&#x2019;s Principal Place of Business</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) as a result of a change in location by the Company of Executive&#x2019;s Principal Place of Business; or</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The failure of the Company to obtain a satisfactory agreement from any successor to materially assume and materially agree to perform under the terms of this Agreement. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.18</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Termination Date</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the effective date of the Change in Control Termination, the Covered Termination or a termination for Cause, as applicable. </font></div></div><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.533%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">Article 8</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GENERAL PROVISIONS</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employment Status</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  This Agreement does not constitute a contract of employment or impose upon Executive any obligation to remain as an employee, or impose on the Company any obligation (i) to retain Executive as an employee, (ii) to change the status of Executive as an at-will employee or (iii) to change the Company&#x2019;s policies regarding termination of employment.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Any notices provided hereunder must be in writing, and such notices or any other written communication shall be deemed effective upon the earlier of personal delivery (including personal delivery by facsimile) or the third day after mailing by first class mail, to the Company at its primary office location and to Executive at Executive&#x2019;s address as listed in the Company&#x2019;s payroll records.  Any payments made by the Company to Executive under the terms of this Agreement shall be delivered to Executive either in person or at the address as listed in the Company&#x2019;s payroll records.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provisions had never been contained herein. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Waiver</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If either party should waive any breach of any provisions of this Agreement, he, she or it shall not thereby be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.5</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Complete Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  This Agreement, including </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit C</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and the Confidentiality Agreement constitute the entire agreement between Executive and the Company and is the complete, final and exclusive embodiment of their agreement with regard to this subject matter, wholly superseding all written and oral agreements with respect to payments and benefits to Executive in </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the event of employment termination.  It is entered into without reliance on any promise or representation other than those expressly contained herein.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.6</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amendment or Termination of Agreement; Continuation of Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  This Agreement may be changed or terminated only upon the mutual written consent of the Company and Executive.  The written consent of the Company to a change or termination of this Agreement must be signed by an executive officer of the Company (other than Executive) after such change or termination has been approved by the Board.  Unless so terminated, this Agreement shall continue in effect for as long as Executive continues to be employed by the Company or by any surviving entity following any Change in Control.  In other words, if, following a Change in Control, Executive continues to be employed by the surviving entity without a Change in Control Termination and the surviving entity then undergoes a Change in Control, following which Executive is terminated by the subsequent surviving entity in a Change in Control Termination, then Executive shall receive the benefits described in Article 3 hereof.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.7</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  This Agreement may be executed in separate counterparts, any one of which need not contain signatures of more than one party, but all of which taken together will constitute one and the same Agreement.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.8</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Headings</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The headings of the Articles and Sections hereof are inserted for convenience only and shall not be deemed to constitute a part hereof nor to affect the meaning thereof.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.9</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Successors and Assigns</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  This Agreement is intended to bind and inure to the benefit of and be enforceable by Executive, and the Company, and any surviving entity resulting from a Change in Control and upon any other person who is a successor by merger, acquisition, consolidation or otherwise to the business formerly carried on by the Company, and their respective successors, assigns, heirs, executors and administrators, without regard to whether or not such person actively assumes any rights or duties hereunder; provided, however, that Executive may not assign any duties hereunder and may not assign any rights hereunder without the written consent of the Company, which consent shall not be withheld unreasonably.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.10</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Choice of Law</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Because of the Company&#x2019;s and Executive&#x2019;s interests in ensuring that disputes regarding this Agreement are resolved on a uniform basis, the parties agree that all questions concerning the construction, validity and interpretation of this Agreement will be governed by the law of the State of New York, without regard for any conflict of law principles.  Further, the parties consent to the jurisdiction of the state and federal courts of the State of New York for all purposes in connection with this Agreement.  The parties hereby irrevocably waive, to the fullest extent permitted by applicable law, any objection which Executive or the Company may now or hereafter have to the laying of venue of any such dispute brought in such court or any defense of inconvenient forum for the maintenance of such dispute. </font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.11</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Arbitration.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  To ensure the rapid and economical resolution of any disputes that may arise under or relate to this Agreement or Executive&#x2019;s employment relationship, Executive and the Company agree that any and all disputes, claims, or causes of action, in law or equity, arising from or relating to the performance, enforcement, execution, or interpretation of this Agreement, Executive&#x2019;s employment with the Company, or the termination of Executive&#x2019;s employment (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), shall be resolved to the fullest extent permitted by law, by final, binding, and (to the extent permitted by law) confidential arbitration before a single arbitrator in the state where Executive is employed.  The arbitration shall be governed by the Federal Arbitration Act, 9 U.S.C. Section 1 </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">et seq.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as amended, and shall be administered by the Judicial Arbitration &amp; Mediation Services, Inc. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">JAMS</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), in accordance with its then-current Employment Arbitration Rules &amp; Procedures (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">JAMS Rules</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  The JAMS Rules are also available online at </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">http://www.jamsadr.com/rules-employment-arbitration/</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.   The parties or their representatives may also call JAMS at 800.352.5267 if they have questions about the arbitration process.   If the JAMS Rules </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">are inconsistent with the terms of this Agreement, the terms of this Agreement shall govern.  Notwithstanding the foregoing, this provision shall exclude Claims that by law are not subject to arbitration.  The arbitrator shall:  (a) have the authority to compel adequate discovery for the resolution of all Claims and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision including the arbitrator&#x2019;s essential findings and conclusions and a statement of the award.  The Company shall pay all JAMS fees in excess of the amount of filing and other court-related fees Executive would have been required to pay if the Claims were asserted in a court of law.   EXECUTIVE AND THE COMPANY UNDERSTAND AND FULLY AGREE THAT BY ENTERING INTO THIS AGREEMENT, BOTH EXECUTIVE AND THE COMPANY ARE GIVING UP THE CONSTITUTIONAL RIGHT TO HAVE A TRIAL BY JURY, AND ARE GIVING UP THE NORMAL RIGHTS OF APPEAL FOLLOWING THE RENDERING OF A DECISION, EXCEPT AS THE FEDERAL ARBITRATION ACT AND APPLICABLE FEDERAL LAW ALLOW FOR JUDICIAL REVIEW OF ARBITRATION PROCEEDINGS.  Nothing in this Agreement shall prevent either Executive or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration.  Any awards or final orders in such arbitrations may be entered and enforced as judgments or orders in the federal and state courts of any competent jurisdiction in compliance with Section 8.11 of this Agreement.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.12</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Construction of Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In the event of a conflict between the text of this Agreement and any summary, description or other information regarding this Agreement, the text of this Agreement shall control.</font></div></div><div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.13</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Circular 230 Disclaimer</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">THE FOLLOWING DISCLAIMER IS PROVIDED IN ACCORDANCE WITH THE INTERNAL REVENUE SERVICE&#x2019;S CIRCULAR 230 (21 C.F.R. PART 10).  ANY TAX ADVICE CONTAINED IN THIS AGREEMENT IS INTENDED TO BE PRELIMINARY, FOR DISCUSSION PURPOSES ONLY AND NOT FINAL.  ANY SUCH ADVICE IS NOT INTENDED TO BE USED FOR MARKETING, PROMOTING OR RECOMMENDING ANY TRANSACTION OR FOR THE USE OF ANY PERSON IN CONNECTION WITH THE PREPARATION OF ANY TAX RETURN.  ACCORDINGLY, THIS ADVICE IS NOT INTENDED OR WRITTEN TO BE USED, AND IT CANNOT BE USED, BY ANY PERSON FOR THE PURPOSE OF AVOIDING TAX PENALTIES THAT MAY BE IMPOSED ON SUCH PERSON.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the parties have executed this Agreement on the Effective Date written above.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:3.001%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:42.589%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:2.42%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:3.981%;box-sizing:content-box;"></td>
     <td style="width:44.009%;box-sizing:content-box;"></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td colspan="3" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Syndax Pharmaceuticals, Inc.</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">EXECUTIVE</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;border-bottom:0.75pt solid #000000;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Luke J. Albrecht</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;border-bottom:0.75pt solid #000000;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Nick Botwood</font></p></td>
    </tr>
    <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:5.78%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:40.1%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.8%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:6.78%;box-sizing:content-box;"></td>
     <td style="width:41.54%;box-sizing:content-box;"></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;border-bottom:0.75pt solid #000000;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Luke J. Albrecht</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;border-bottom:0.75pt solid #000000;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nick Botwood</font></p></td>
    </tr>
    <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;border-bottom:0.75pt solid #000000;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General Counsel</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;border-bottom:0.75pt solid #000000;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;border-bottom:0.75pt solid #000000;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:27pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit A:	Release (Individual Termination &#x2013; Age 40 or Older)</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit B:	Release (Individual and Group Termination &#x2013; Under Age 40)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit C:	Release (Group Termination &#x2013; Age 40 or Older)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</font><font style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT A</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RELEASE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(INDIVIDUAL TERMINATION &#x2013; AGE 40 OR OLDER)</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain capitalized terms used in this Release are defined in the Executive Employment Agreement (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) which I have executed and of which this Release is a part.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I hereby confirm my obligations under the Confidentiality Agreement (or other comparable agreement that I have signed, if any).</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as otherwise set forth in this Release, I hereby release, acquit and forever discharge the Company, its parents and subsidiaries, and their officers, directors, agents, servants, employees, shareholders, successors, assigns and affiliates, of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys&#x2019; fees, damages, indemnities and obligations of every kind and nature, in law, equity or otherwise, known and unknown, suspected and unsuspected, disclosed and undisclosed (other than any claim for indemnification I may have as a result of any third party action against me based on my employment with the Company), arising out of or in any way related to agreements, events, acts or conduct at any time prior to the date I execute this Release, including, but not limited to: all such claims and demands directly or indirectly arising out of or in any way connected with my employment with the Company or the termination of that employment, including, but not limited to, claims of intentional and negligent infliction of emotional distress, any and all tort claims for personal injury, claims or demands related to salary, bonuses, commissions, stock, stock options, or any other ownership interests in the Company, vacation pay, fringe benefits, expense reimbursements, severance pay, or any other form of compensation; and claims pursuant to any federal, state or local law or cause of action including, but not limited to, the federal Civil Rights Act of 1964, as amended, the federal Age Discrimination in Employment Act of 1967, as amended (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ADEA</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the federal Employee Retirement Income Security Act of 1974, as amended, the federal Americans with Disabilities Act of 1990, the California Fair Employment and Housing Act, as amended, the New York City Human Rights Law, as amended, the Massachusetts Fair Employment Practices Law, as amended, the South Carolina Human Affairs Law, as amended, tort law, contract law, wrongful discharge, discrimination, fraud, defamation, emotional distress, and breach of the implied covenant of good faith and fair dealing; provided, however, that nothing in this paragraph shall be construed in any way to (1) release the Company from its obligation to indemnify me pursuant to the Company&#x2019;s indemnification obligation pursuant to written agreement or applicable law; (2) release any claim by me against the Company relating to the validity or enforceability of this release or the Agreement; (3) prohibit me from exercising any non-waivable right to file a charge with the United </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">States</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Equal Employment Opportunity Commission (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EEOC</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the National Labor Relations Board (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">NLRB</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), or any other government agency (provided, however, that I shall not be entitled to recover any monetary damages or to obtain non-monetary relief if the agency were to pursue any claims relating to my employment with the Company).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have to assert claims for age discrimination under applicable law, including under the ADEA.  I also acknowledge that the consideration given under the Agreement for the waiver and release in the preceding paragraph hereof is in addition to anything of value to which I was already entitled.  I further acknowledge that I have been advised by this writing, as required by the ADEA, that: (A) my waiver and release do not apply to any rights or claims that may arise on or after the date I execute this Release; (B) I have the right to consult with an attorney prior to executing this Release; (C) I have twenty-one (21) days to consider this Release (although I may choose to voluntarily execute this Release earlier); (D) I have seven (7) days following my execution of this Release to revoke the Release by providing a written notice of revocation to the</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A-</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company&#x2019;s Chief Executive Officer; and (E) this Release shall not be effective until the date upon which the revocation period has expired, which shall be the eighth (8th) day after I execute this Release (provided that I do not revoke it).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I hereby represent that I have been paid all compensation owed and for all hours worked, I have received all the leave and leave benefits and protections for which I am eligible, pursuant to the federal Family and Medical Leave Act, any Company policy or applicable law, and I have not suffered any on-the-job injury or illness for which I have not already filed a workers&#x2019; compensation claim.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I agree that I will not make any disparaging statements regarding the Company or its officers, directors, shareholders, members, agents or products jointly or severally.  The foregoing shall not be violated by truthful statements in response to legal process, required governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXECUTIVE:</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">						</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Signature</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">						</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Printed Name</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">						</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A-</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font><font style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT B</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RELEASE</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(INDIVIDUAL AND GROUP TERMINATION &#x2013; UNDER AGE 40)</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain capitalized terms used in this Release are defined in the Executive Employment Agreement (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) which I have executed and of which this Release is a part.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I hereby confirm my obligations under the Confidentiality Agreement (or other comparable agreement that I have signed, if any).</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as otherwise set forth in this Release, I hereby release, acquit and forever discharge the Company, its parents and subsidiaries, and their officers, directors, agents, servants, employees, shareholders, successors, assigns and affiliates, of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys&#x2019; fees, damages, indemnities and obligations of every kind and nature, in law, equity or otherwise, known and unknown, suspected and unsuspected, disclosed and undisclosed (other than any claim for indemnification I may have as a result of any third party action against me based on my employment with the Company), arising out of or in any way related to agreements, events, acts or conduct at any time prior to the date I execute this Release, including, but not limited to: all such claims and demands directly or indirectly arising out of or in any way connected with my employment with the Company or the termination of that employment, including, but not limited to, claims of intentional and negligent infliction of emotional distress, any and all tort claims for personal injury, claims or demands related to salary, bonuses, commissions, stock, stock options, or any other ownership interests in the Company, vacation pay, fringe benefits, expense reimbursements, severance pay, or any other form of compensation; and claims pursuant to any federal, state or local law or cause of action including, but not limited to, the federal Civil Rights Act of 1964, as amended, the federal Employee Retirement Income Security Act of 1974, as amended, the federal Americans with Disabilities Act of 1990, the California Fair Employment and Housing Act, as amended, the New York City Human Rights Law, as amended, the Massachusetts Fair Employment Practices Law, as amended, the South Carolina Human Affairs Law, as amended, tort law, contract law, wrongful discharge, discrimination, fraud, defamation, emotional distress, and breach of the implied covenant of good faith and fair dealing;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided, however, that nothing in this paragraph shall be construed in any way to  (1) release the Company from its obligation to indemnify me pursuant to the Company&#x2019;s indemnification obligation pursuant to written agreement or applicable law; (2) release any claim by me against the Company relating to the validity or enforceability of this release or the Agreement; (3) prohibit me from exercising any non-waivable right to file a charge with the United States Equal Employment Opportunity Commission (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EEOC</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the National Labor Relations Board (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">NLRB</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), or any other government agency (provided, however, that I shall not be entitled to recover any monetary damages or to obtain non-monetary relief if the agency were to pursue any claims relating to my employment with the Company).</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I acknowledge that the consideration given under the Agreement for the waiver and release in the preceding paragraph hereof is in addition to anything of value to which I was already entitled.  I further acknowledge that I have been advised by this writing that: (A) my waiver and release do not apply to any rights or claims that may arise on or after the date I execute this Release; (B) I have the right to consult with an attorney prior to executing this Release; and (C) I have twenty-one (21) days to consider this Release (although I may choose to voluntarily execute this Release earlier).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I hereby represent that I have been paid all compensation owed and for all hours worked, I have received all the leave and leave benefits and protections for which I am eligible, pursuant to the federal Family and Medical Leave Act, any Company policy or applicable law, and I have not suffered any on-the-job injury or illness for which I have not already filed a workers&#x2019; compensation claim.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I agree that I will not make any disparaging statements regarding the Company or its officers, directors, shareholders, members, agents or products jointly or severally.  The foregoing shall not be violated by truthful statements in response to legal process, required governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXECUTIVE:</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">						</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Signature</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">						</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Printed Name</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">						</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font><font style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT C</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RELEASE</font></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(GROUP TERMINATION &#x2013; AGE 40 OR OLDER)</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain capitalized terms used in this Release are defined in the Executive Employment Agreement (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) which I have executed and of which this Release is a part.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I hereby confirm my obligations under the Confidentiality Agreement (or other comparable agreement that I have signed, if any).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as otherwise set forth in this Release, I hereby release, acquit and forever discharge the Company, its parents and subsidiaries, and their officers, directors, agents, servants, employees, shareholders, successors, assigns and affiliates, of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys&#x2019; fees, damages, indemnities and obligations of every kind and nature, in law, equity or otherwise, known and unknown, suspected and unsuspected, disclosed and undisclosed (other than any claim for indemnification I may have as a result of any third party action against me based on my employment with the Company), arising out of or in any way related to agreements, events, acts or conduct at any time prior to the date I execute this Release, including, but not limited to: all such claims and demands directly or indirectly arising out of or in any way connected with my employment with the Company or the termination of that employment, including, but not limited to, claims of intentional and negligent infliction of emotional distress, any and all tort claims for personal injury, claims or demands related to salary, bonuses, commissions, stock, stock options, or any other ownership interests in the Company, vacation pay, fringe benefits, expense reimbursements, severance pay, or any other form of compensation; and claims pursuant to any federal, state or local law or cause of action including, but not limited to, the federal Civil Rights Act of 1964, as amended, the federal Age Discrimination in Employment Act of 1967, as amended (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ADEA</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the federal Employee Retirement Income Security Act of 1974, as amended, the federal Americans with Disabilities Act of 1990, the California Fair Employment and Housing Act, as amended, the New York City Human Rights Law, as amended, the Massachusetts Fair Employment Practices Law, as amended, the South Carolina Human Affairs Law, as amended, tort law, contract law, wrongful discharge, discrimination, fraud, defamation, emotional distress, and breach of the implied covenant of good faith and fair dealing; provided, however, that nothing in this paragraph shall be construed in any way to (1) release the Company from its obligation to indemnify me pursuant to the Company&#x2019;s indemnification obligation pursuant to written agreement or applicable law; (2) release any claim by me against the Company relating to the validity or enforceability of this release or the Agreement; (3) prohibit me from exercising any non-waivable right to file a charge with the United States Equal Employment Opportunity Commission (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EEOC</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the National Labor Relations Board (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">NLRB</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), or any other government agency (provided, however, that I shall not be entitled to recover any monetary damages or to obtain non-monetary relief if the agency were to pursue any claims relating to my employment with the Company).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have to assert claims for age discrimination under applicable law, including under the ADEA.  I also acknowledge that the consideration given under the Agreement for the waiver and release in the preceding paragraph hereof is in addition to anything of value to which I was already entitled.  I further acknowledge that I have been advised by this writing, as required by the ADEA, that: (A) my waiver and release do not apply to any rights or claims that may arise on or after the date I execute this Release; (B) I have the right to consult with an attorney prior to executing this Release; (C) I have forty-five (45) days to consider this Release (although I may choose to voluntarily execute this Release earlier); (D) I have seven (7) days following my execution of this Release to revoke the Release by providing a written notice of revocation to the Company&#x2019;s Chief</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">C-</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive Officer; (E) this Release shall not be effective until the date upon which the revocation period has expired, which shall be the eighth day (8th) after I execute this Release; and (F) I have received with this Release the required written disclosure for a &#x201c;group termination&#x201d; under the ADEA, including a detailed list of the job titles and ages of all employees who were terminated in this group termination and the ages of all employees of the Company in the same job classification or organizational unit who were not terminated.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I hereby represent that I have been paid all compensation owed and for all hours worked, I have received all the leave and leave benefits and protections for which I am eligible, pursuant to the federal Family and Medical Leave Act, any Company policy or applicable law, and I have not suffered any on-the-job injury or illness for which I have not already filed a workers&#x2019; compensation claim.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I agree that I will not engage in any conduct that is injurious to the reputation of the Company or its parents, subsidiaries and affiliates, including but not limited to disparagement of the Company, its officers, Board members, employees and shareholders.  The foregoing shall not be violated by a statement made in a deposition, trial or administrative proceeding in response to legal process; by any statement made to a government agency; or whenever I make any statement to a court, administrative tribunal or government agency as required by law.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXECUTIVE:</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">						</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Signature</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">						</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Printed Name</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">						</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">C-</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font><font style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>sndx-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img199102934_0.jpg" alt="img199102934_0.jpg" style="width:223px;height:53px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer</font></h2><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"></font>&#160;</h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">- Dr. Nicholas Botwood comes to Syndax from BMS and brings 25 years of industry experience leading drug development, R&amp;D strategy and global commercialization of novel oncology therapeutics -</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced the appointment of Dr. Nicholas Botwood BSc (Hons), MBBS, MFPM, FRCP, to the role of Head of Research and Development (R&amp;D) and Chief Medical Officer. Dr. Botwood brings to Syndax over 25 years of industry experience, most recently serving as the Head of Worldwide Medical Oncology at Bristol Myers Squibb, where he oversaw all medical activities in its oncology portfolio, including new asset launches, data generation, medical education and commercial strategy. Dr. Botwood will drive Syndax's R&amp;D strategy and development, succeeding Dr. Neil Gallagher, who is departing to pursue other opportunities.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;Nick is a prominent leader and R&amp;D visionary who brings deep strategic and operational experience, and a proven track record of developing novel medicines into industry-leading franchises,&#x201d; said Michael A. Metzger, Chief Executive Officer. &#x201c;Nick&#x2019;s unique mix of commercial, medical and clinical oncology development experience will enable us to accelerate the expansion of our two best-in-class franchises and fully unlock their multi-billion potential. We look forward to his many contributions.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">   </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Prior to joining Syndax, Dr. Botwood served as Senior Vice President, Head of Worldwide Medical Oncology at Bristol Myers Squibb since 2022.  From 2022 to 2020, he served as Senior Vice President, Head U.S. Medical where he was accountable for the medical strategy in the United States across commercial and development, including hematology and oncology.  Prior to this role, Dr. Botwood held senior clinical development roles at Bristol Myers Squibb from 2015 to 2020, including Head of Oncology Clinical Development and Development Team Lead.  Prior to Bristol Myers Squibb, he joined AstraZeneca from 2003 to 2015, where he took on the role of Vice President, Head of Oncology Clinical and Head of Global Clinical Operations. Dr. Botwood holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Imperial College London and a Bachelor of Science (BSc) from University College London.  He is a member of the Faculty of Pharmaceutical Medicine and an elected Fellow of the Royal College of Physicians UK.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;Syndax is a proven innovator at the forefront of oncology with medicines that address some of the toughest challenges in treating cancer,&#x201d; said Dr. Botwood. &#x201c;The Company has an impressive track record of developing and commercializing first- and best-in-class medicines and driving execution across its portfolio, with a robust development strategy underway for expansion and to further differentiate its drugs. I look forward to working alongside the talented team at Syndax to support its commitment to innovation and shape the future of cancer treatment.&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Mr. Metzger added, &#34;We thank Neil for his exceptional contributions during his time at Syndax, which include multiple positive data readouts and two product approvals, along with the recent submission of the Revuforj supplemental New Drug Application for relapsed or refractory mNPM1 acute myeloid leukemia. Neil built a strong R&amp;D organization that will continue to deliver on our ambitious plans for the future, and accordingly, we are in an excellent position to transition R&amp;D leadership to Nick, who will spearhead this next chapter of growth for Syndax.&#34;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">About Syndax</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#174;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> (revumenib), an FDA-approved menin inhibitor, and Niktimvo&#153; (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">www.syndax.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> or follow the Company on </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">X</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> and </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">LinkedIn</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Forward-Looking Statements</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as &#34;anticipate,&#34; &#34;believe,&#34; &#34;could,&#34; &#34;estimate,&#34; &#34;expects,&#34; &#34;intend,&#34; &#34;may,&#34; &#34;plan,&#34; &#34;potential,&#34; &#34;predict,&#34; &#34;project,&#34; &#34;should,&#34; &#34;will,&#34; &#34;would&#34; or the negative or plural of those terms, and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on Syndax's expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from these forward-looking statements. Forward-looking statements contained in this press release include, but are not limited to, statements about the progress, timing, clinical development and scope of clinical trials, the reporting of clinical data for Syndax's product candidates, the acceptance of Syndax and its partners' products in the marketplace, sales, marketing, manufacturing and distribution requirements, and the potential use of its product candidates to treat various cancer indications and fibrotic diseases. Many factors may cause differences between current</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">expectations and actual results, including: unexpected safety or efficacy data observed during preclinical or clinical trials; clinical trial site activation or enrollment rates that are lower than expected; changes to Revuforj's or Niktimvo&#x2019;s commercial availability; changes in expected or existing competition; changes in the regulatory environment; failure of Syndax's collaborators to support or advance collaborations or product candidates; and unexpected litigation or other disputes. Other factors that may cause Syndax's actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Syndax's filings with the U.S. Securities and Exchange Commission, including the &#34;Risk Factors&#34; sections contained therein. Except as required by law, Syndax assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Syndax Contacts</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Sharon Klahre<br>Syndax Pharmaceuticals, Inc.<br></font><font><font style="white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">sklahre@syndax.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"><br>Tel 781.684.9827</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">SNDX-G</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img199102934_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img199102934_0.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M&OCC]EG_ ). \%_]?C?^BWKIIVY&SEJ-\Z1^I5%%%<QU!1110 4444 %%%%
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MSQ]_PFGQJU"UADWV6AQKIT0!XWJ2TIQZ[V*GV05K3CS2,JDN6):_9FU;QO\
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M?% 'S6^_$%KQP96')/(.P<XZE<C/Q/XZ_:(^(/Q"N)&U3Q+>16SDXLK&0V\
M'IL4C./5B3[URWACPUK?Q*\76VE:=')J.LZE,0&D8DLQ)+.['/ &6)/0 FOT
M.^#?[)_@_P"%^GV\]_90>(?$. TM]>QAT1O2*,Y"@=B1N[Y'0=/NTUKJSFO*
MH]-$?G'#I6JZHOVB*SO+L$Y\U(F<9^H!JYIOBCQ'X3N0;#5M4T>X4Y_<7$D+
M#\B#7Z_JH10JJ% X %4M8T#3/$%J;;5-.M=2MSUANX5E0_@P(I>V[H?L;;,_
M+GQ+^T)XW\:>")?"WB#5O[8TYY8Y5DNHE\]"AR,2  D'/.[)]Q5S]EG_ ).
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MQ'=?VU::8VRTT;.VWA?^)Y%SF1R1WPH&!@\D^E_6O,_'7AG4['5I-=TQG&X
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M\%_!?0;'Q-\6/"6E:E +G3[O4H8IX6) =2PRI((.#T..U?>G[:G_ ";WKO\
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MN1C'?.:XRMZ<5&^MS"<G*VA^PWA%BWA/16)R390DGW\M:V*Q_!__ "*.A_\
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M.*.35HKCQ3?J,M)?.4AS[1(0,>S%J]MT'P?H7A6$1:-HNGZ5'C&VRMDA&/\
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MD= %6OLW]MCX>?\ "9?!^;5+>+??Z!*+U=HRQA/RS#Z8(<_]<Z_.0 DXZGH
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MD\;1R(LD;##*PR"#U!'>I:* ,[_A'=*_Z!MG_P" Z_X5>55C4*H 4#  I]%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!YO\??C#I_P-^&.K>*+W;)/$ODV-JQQ]HN6!$<8]L@DXZ*K'M7
MY^_!W]B_X@?M#Z]-XP\<W%QX=TC4IVNY[RZC_P!,O2QW$QQG&U3GAFX (P&%
M?H5KW@_1O&'Q-LI=;T^'5#HMFEUIZ70+QP322.&D"'Y2^(U 8@E<'!&3GOOX
M:[Z6(>'ARTU[SZGB8G 1QU;FKOW([+S\SA?A3\%_"'P6T$:5X4TB+3T8#SKE
MOGN+@C^*20\L>O'09P !Q7=4?Q4O:N&4G)W;NSUX4XTH\D%9"T444C0****
3"BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>sndx-20250512.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-05-16T10:29:26.1916+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.syndax.com/20250512" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:sndx="http://www.syndax.com/20250512" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="sndx-20250512.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>May 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 12,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SYNDAX PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001395937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">32-0162505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">730 THIRD AVENUE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">FLOOR 9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">NEW YORK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">419-1400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SNDX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ..!L%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( ..!L%K[[)9@[P   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%JPS ,AE]E^)[(24D')O5E8Z<6!BML[&9L
MM36+8V-K)'W[)5Z;,K8'V-'2[T^?0*T.0ON(S]$'C&0QW8VNZY/08<-.1$$
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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M-6=05.8"^'TII3X.S#MU]I=([U]02P,$%     @ XX&P6I^@&_"Q @  X@P
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MU\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK
M>MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ
M!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.
M\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( ..!L%I&QTU(E0   ,T
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ XX&P6OOLEF#O    *P(  !$              ( !PP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ XX&P6IE<G",0!@  G"<  !,
M     ( !X0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #C@;!:
M(JR-%F0$   >$0  &               @($B"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ XX&P6I^@&_"Q @  X@P   T
M     ( !O P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #C@;!:EXJ[',
M   3 @  "P              @ &8#P  7W)E;',O+G)E;'-02P$"% ,4
M" #C@;!:.JJBYT !   \ @  #P              @ &!$   >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ XX&P6B0>FZ*M    ^ $  !H
M ( ![A$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
MXX&P6F60>9(9 0  SP,  !,              ( !TQ(  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&      D "0 ^ @  '10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="sndx-20250512.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="sndx-20250512.htm">sndx-20250512.htm</File>
    <File>sndx-20250512.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "sndx-20250512.htm": {
   "nsprefix": "sndx",
   "nsuri": "http://www.syndax.com/20250512",
   "dts": {
    "inline": {
     "local": [
      "sndx-20250512.htm"
     ]
    },
    "schema": {
     "local": [
      "sndx-20250512.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sndx-20250512.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sndx-20250512.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.syndax.com/20250512/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000950170-25-073555-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-073555-xbrl.zip
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M'\EB,N2N<-*H.HD3HG:VO3<D]DDVXOAJFH &":/L7[DC%IUS=!3A:]76C0I
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M3'RY5#9]US-=6Z6^:7)J6(9'[2XH]+;#--;17:XR=3U2^2!RXP1L"Q'?'69
M"X-X&F7);!![=7T>X],8=\KX)(DOL)\G5N3W>,@N6<+OHL2_9&OUCCBC.HYO
MZMRFOMNUJ:'YC#JJ[E#?83K3NJKG=#KKP9F/0<AA;(<G3[K_BJ)2W305JT&
MY4P#=DSS&*CRGJY3PW0MZBB^#9S#ZYI=US+AO_4@P!F[.LACV:Y@',^ #;I&
M%;6+J0#W,NJ7B"SS!Y-84K-?/_8]S?YN"V&$GMSC;,03\J]I$J1>(%R\(G +
M!D9->+W90/I_X5LPB,?C(,7L2X(\GT@R;P"]=D ?G [)_G@2QC.>".2NLU=R
M%+>70WTI/WO=3OY;]_+FW;NG";XA--" K0%; [8&;(\#ML;9\UAVF\LZONJ
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MQ,MIE&?_I=>#%4X<APX#!,D 31^RT'_\9)N&L7N;SK<Y6)<#",!<A1"95.I
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M->&YSJF!)<!7P?.\[0*>K[W,E_T$9;[6*"SG^INTF7@"5M=D6?$OP5!R&PJ
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ME;%;I;.D</^\7K].MI&6S5W,X=7M71'&+;Z!T0#))EA8%C.'I -6<ZBVXET
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M/H=N@#EK9/O#T,T__AH!/T^ '\P6/F_#HH3GAHPY'D4M>.%'Y@+K%5SO9,3
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M?WK8'^Q_/3L8]+\,6^3@:+"\,-=2'MOPU5>([0W0&J U0/L!2DP^FGQ[XMK
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MG(+9%F!'"&B<28V4+J.ZA73H:[_JDB_3 SJR&PG["7):5D28 \_F-:1Z./*
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MARI6_!$&X5!0Q!%8CBR9!.!!X>5H7"Y]3'4"0V8%3+G&BK%UN;XFJ.JFO3*
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M,0RU[16"YT!OWVX$O1T"[,:%C$PY:7N5.D9^AXU*N$JONVE=THKZL@7_V^A
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MD,%+9UIP7/DW;\/3YLVGS4]2".31:3.7T^"T[HX1Z#^F,L'5H=LZ5Y0Q2/&
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M(JA@()*&X8ES4#'@1]@>[/5TP(]:F,*. #@L+^L7$#JCP>6GT2FNF\X!9OL
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M!5_$.4:4P)@E 4VG43Q#*G-?8'^]&>A!  C/=1EZW:31'NLV'H >\3SB=1J
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MK)34.+B4I'WCE3K&!Q \()NI8N'>.%#N4G@D@T%F6+(#:X $]N=B&A0&:7(
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M+#;A4R-HW X@?!<_%HX!#$8DPE>]=L<>>F;I\*8BF@##:/-H(J\ -7%JE4Q
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M#76.UIIJ!QDA 91<S*%3:!AFK US$^P*(5$0#?8S 7;DD/S4"!:K&GZJ*VI
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MRG#XOUJ^MW63CM;N_V/K)O_?'_X/4$L! A0#%     @ XX&P6B6_\258(
MRR4! !$              ( !     '-N9'@M,C R-3 U,3(N:'1M4$L! A0#
M%     @ XX&P6J*21S&!"   $V$  !$              ( !AR   '-N9'@M
M,C R-3 U,3(N>'-D4$L! A0#%     @ XX&P6B_!D=<,7   Z\\#  \
M         ( !-RD  '-N9'@M97@Q,%\Q+FAT;5!+ 0(4 Q0    ( ..!L%J3
MRBBPU X   1"   /              "  7"%  !S;F1X+65X.3E?,2YH=&U0
52P4&      0 ! #X    <90

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>sndx-20250512_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sndx-20250512.xsd" xlink:type="simple"/>
    <context id="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001395937</identifier>
        </entity>
        <period>
            <startDate>2025-05-12</startDate>
            <endDate>2025-05-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_d1838164-9742-4c00-8f92-76078a34e3fe">0001395937</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_b16290c2-060e-4dd6-8a41-4c00a25b24b8">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_93c76d3e-6477-4e11-ba05-a1c26f448387">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_c2a07f97-f57a-492e-8137-660863b27396">2025-05-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_2a96dddf-54a4-4480-b628-72b8c6352890">SYNDAX PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_7fcd7c91-f77e-484d-9697-9ba2a53ce1a1">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_1bbf73e9-fc69-42fa-b13b-fba3a261db55">001-37708</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_71802daf-5d33-47c8-b0f9-96d676c87777">32-0162505</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_ca5f1bf5-b2a7-4caf-8a87-2515c0d9cc3e">730 THIRD AVENUE</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_32e30c97-e842-417d-9efc-b7fb42157963">FLOOR 9</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_87a8d23f-5dae-4027-8931-d1dd4dbbb96e">NEW YORK</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_c25e4f8a-ecd7-40a9-a56d-0108a7a76376">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_8f83b23e-3646-4953-adec-a21ede8b53b1">10017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_48922bc2-db04-42ab-bd58-67d03a94c88e">(781)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_1f0b21e7-cd59-47dd-9631-e97abda2e9f1">419-1400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_df0cc342-c6ba-430f-bec6-25200f78cb7e">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_3ce450b3-30c0-4e73-8e7e-2fa7f23a9991">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_61e60b87-1a0b-49b8-aabf-d1079bde03c2">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_3c4a1cfa-7437-4599-8045-9cab6d3a68f1">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_ca6bbd95-5798-4ac0-8520-1be4000707d6">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_cd299d99-e0e9-4de1-b0fa-75f8180759b0">SNDX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_9b151207-b770-4df6-bf80-b02a232bc832">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_7489b7c7-d4f5-4ece-8948-6dc0180b02ff"
      id="F_405f8448-c9d3-4ab2-872f-9f198861ded1">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
